Clearview Wealth Advisors LLC Eli Lilly & CO Transaction History

Clearview Wealth Advisors LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 09, 2024	SELL	$592.2 - $792.28 $482,050 - $644,915	-814 Reduced 61.11%	518 $402,000
Q4 2023 Jan 12, 2024	BUY	$525.19 - $619.13 $699,553 - $824,681	1,332 New	1,332 $776,000
Q2 2023 Aug 07, 2023	BUY	$350.74 - $468.98 $591,698 - $791,169	1,687 Added 1041.36%	1,849 $867,000
Q1 2023 Apr 12, 2023	SELL	$310.63 - $364.82 $1,863 - $2,188	-6 Reduced 3.57%	162 $55,000
Q4 2022 Jan 31, 2023	BUY	$321.55 - $374.67 $1,929 - $2,248	6 Added 3.7%	168 $61,000
Q3 2022 Oct 18, 2022	BUY	$296.48 - $337.87 $296 - $337	1 Added 0.62%	162 $52,000
Q1 2022 Apr 29, 2022	SELL	$234.69 - $291.66 $57,264 - $71,165	-244 Reduced 60.25%	161 $46,000
Q4 2021 Feb 02, 2022	BUY	$224.85 - $279.04 $4,272 - $5,301	19 Added 4.92%	405 $112,000
Q3 2021 Nov 02, 2021	SELL	$221.6 - $272.71 $28,586 - $35,179	-129 Reduced 25.05%	386 $89,000
Q2 2021 Jul 30, 2021	BUY	$180.55 - $233.54 $16,068 - $20,785	89 Added 20.89%	515 $118,000
Q4 2020 Jan 21, 2021	BUY	$130.46 - $172.63 $55,575 - $73,540	426 New	426 $72,000

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $755B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Clearview Wealth Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Clearview Wealth Advisors LLC with notifications on news.